Shandong Stock Watch | Digital People 2025 Annual Report: Revenue Growth Exceeds 50%, Returns to Profitability, International Business Becomes New Growth Driver

Recently, Shandong Digital Human Technology Co., Ltd. (hereinafter referred to as “Digital Human,” stock code: 920670) officially disclosed its 2025 annual report.

The report shows that Digital Human achieved operating revenue of 99.6549 million yuan in 2025, a year-on-year increase of 50.22%; net profit attributable to shareholders of the listed company was 8.1841 million yuan, turning from loss to profit with a growth of 296.77%; excluding non-recurring gains and losses, net profit was 4.0009 million yuan, up 132.09% year-on-year.

Image source: Visual China Group

Turning losses into profits

Shandong Digital Human Technology Co., Ltd. was established in April 2002 and listed on the Beijing Stock Exchange in December 2020. It is a software development company focused on the digital medical field.

The company engages in the research and development and application promotion of “digital human technology” by leveraging technological innovations and accumulation in areas such as digital human visualization technology, multi-modal data fusion analysis, tomographic image segmentation, 3D reconstruction and visualization processing, and system application development. It also provides medical education informatization products and comprehensive solutions for clients.

Notably, the annual report shows that net profit attributable to shareholders of the listed company in 2025 shifted from a loss of 4.1592 million yuan in the same period of 2024 to a profit of 8.1841 million yuan.

Regarding the main reasons for the performance change, Digital Human stated in its announcement that during the reporting period, the company increased market development and implementation efforts, completing some projects deferred from the end of the previous year and winning new projects during this period, which led to increased revenue and profit growth.

According to Digital Human’s disclosed 2025 annual profit distribution plan, the company plans to distribute a cash dividend of 0.6 yuan (tax included) per 10 shares to all shareholders. Based on the total share capital of 106,182,400 shares, the total dividend amount is approximately 6.3709 million yuan.

Deepening Digital Medical Education, International Business Becomes a New Focus

Currently, the strategic value of medical education informatization is increasingly prominent. Under the trend of “digital-physical integration,” it not only effectively alleviates issues such as uneven distribution of medical resources and shortages of medical education resources but also serves as an important testing ground for cultivating new productive forces.

Through technologies such as cloud collaboration, AI empowerment, and virtual simulation, medical education informatization gathers vast medical knowledge resources, enabling the widespread sharing of high-quality medical education resources and promoting educational equity; at the same time, it relies on digital means to innovate teaching models, creating new scenarios such as virtual patients, AI surgical simulation, and blockchain verification, with virtual teaching scenes effectively improving the quality and efficiency of medical education.

The government continues to guide educational institutions to increase investment in education informatization through multiple channels, encouraging enterprises to participate in course resource creation and infrastructure development, and promoting the popularization of informatization products and resources, with industry development potential continuously unleashed.

It is understood that digital medical education is a major business segment of Digital Human. Currently, its products are widely used in over 500 medical colleges and dozens of science and technology exhibition halls nationwide.

Meanwhile, Digital Human stated that international business is a new market it is actively developing. With breakthroughs in product technology and quality improvement, its products have been piloted and sold in more than 40 countries and regions overseas. In the future, the company will continue to leverage this as a business support point to expand its market share in new markets.

Text: Niu Xingjun